The stock of SeaSpine Holdings Corp (NASDAQ:SPNE) is a huge mover today! About 77,473 shares traded hands or 256.89% up from the average. SeaSpine Holdings Corp (NASDAQ:SPNE) has declined 27.21% since March 7, 2016 and is downtrending. It has underperformed by 34.80% the S&P500.
The move comes after 7 months negative chart setup for the $115.12M company. It was reported on Oct, 10 by Barchart.com. We have $8.80 PT which if reached, will make NASDAQ:SPNE worth $14.97M less.
Analysts await SeaSpine Holdings Corp (NASDAQ:SPNE) to report earnings on November, 10. They expect $-0.54 earnings per share, up 57.48% or $0.73 from last year’s $-1.27 per share. After $-1.07 actual earnings per share reported by SeaSpine Holdings Corp for the previous quarter, Wall Street now forecasts -49.53% EPS growth.
According to Zacks Investment Research, “SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California.”
More notable recent SeaSpine Holdings Corp (NASDAQ:SPNE) news were published by: Globenewswire.com which released: “SeaSpine Holdings Corporation Announces Additions to Management Team” on July 27, 2015, also Globenewswire.com with their article: “SeaSpine Launches Ventura(TM) NanoMetalene(R) Interbody Device” published on August 10, 2015, Reuters.com published: “BRIEF-Seaspine Holdings files for mixed shelf of upto $150 mln – SEC filin…” on August 11, 2016. More interesting news about SeaSpine Holdings Corp (NASDAQ:SPNE) were released by: Globenewswire.com and their article: “Integra LifeSciences Completes Spin-Off of SeaSpine” published on July 01, 2015 as well as Globenewswire.com‘s news article titled: “SeaSpine Announces Preliminary Second Quarter 2015 Revenue and Provides …” with publication date: July 30, 2015.
SPNE Company Profile
SeaSpine Holdings Corporation, incorporated on February 12, 2015, is a medical technology company. The Firm is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Firm operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. The Firm has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.